交易 ALX Oncology Holdings Inc. - ALXO CFD
新增到我的最愛- 摘要
- 曆史數據
- 活動
- 盈虧控制
- 資産負債表
- 現金流
交易條件
價差 | 0.05 | ||||||||
多頭倉位隔夜費用
多頭隔夜費用
前往平台 | -0.026179% | ||||||||
空頭倉位隔夜費用
空頭隔夜費用
前往平台 | 0.003957% | ||||||||
隔夜費時間 | 21:00 (UTC) | ||||||||
最小成交量 | 1 | ||||||||
貨幣 | USD | ||||||||
保證金 | 5% | ||||||||
股票交易 | United States of America | ||||||||
交易委員會 | 0% |
*Information provided by Capital.com
ALX Oncology Holdings Inc ESG Risk Ratings
High Medium Low Negligible
“C”分數表示在公開報告重大 ESG 數據方面令人滿意的相對 ESG 表現和適度的透明度。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 拋售 | 自訂 | 變化 (%) | 打開 | 最高 | 最小 |
---|---|---|---|---|---|---|
Apr 18, 2024 | 15.69 | -0.05 | -0.32% | 15.74 | 16.03 | 15.07 |
Apr 17, 2024 | 16.05 | 1.56 | 10.77% | 14.49 | 17.00 | 14.49 |
Apr 16, 2024 | 14.42 | 2.07 | 16.76% | 12.35 | 14.54 | 12.35 |
Apr 15, 2024 | 12.82 | 0.14 | 1.10% | 12.68 | 13.02 | 12.11 |
Apr 12, 2024 | 13.02 | -0.02 | -0.15% | 13.04 | 13.48 | 12.48 |
Apr 11, 2024 | 13.35 | 1.35 | 11.25% | 12.00 | 13.67 | 11.78 |
Apr 10, 2024 | 12.01 | 0.22 | 1.87% | 11.79 | 12.11 | 11.64 |
Apr 9, 2024 | 12.32 | 0.13 | 1.07% | 12.19 | 12.52 | 11.77 |
Apr 8, 2024 | 12.14 | 0.15 | 1.25% | 11.99 | 12.68 | 11.99 |
Apr 5, 2024 | 12.24 | 1.18 | 10.67% | 11.06 | 12.25 | 10.68 |
Apr 4, 2024 | 11.23 | 0.44 | 4.08% | 10.79 | 11.27 | 10.79 |
Apr 3, 2024 | 10.79 | 0.06 | 0.56% | 10.73 | 10.91 | 10.48 |
Apr 2, 2024 | 10.70 | 0.21 | 2.00% | 10.49 | 10.91 | 10.49 |
Apr 1, 2024 | 11.01 | 0.10 | 0.92% | 10.91 | 11.30 | 10.60 |
Mar 28, 2024 | 11.15 | -0.24 | -2.11% | 11.39 | 11.44 | 10.55 |
Mar 27, 2024 | 11.39 | 0.21 | 1.88% | 11.18 | 11.59 | 10.94 |
Mar 26, 2024 | 11.17 | -0.62 | -5.26% | 11.79 | 11.82 | 11.16 |
Mar 25, 2024 | 11.70 | 0.19 | 1.65% | 11.51 | 12.14 | 11.47 |
Mar 22, 2024 | 11.73 | -0.42 | -3.46% | 12.15 | 12.32 | 11.46 |
Mar 21, 2024 | 12.48 | 0.61 | 5.14% | 11.87 | 12.65 | 11.84 |
ALX Oncology Holdings Inc. Events
時間 (UTC) | 國家 | 事件 |
---|---|---|
Thursday, May 9, 2024 | ||
時間 (UTC) 10:59 | 國家 US
| 事件 Q1 2024 ALX Oncology Holdings Inc Earnings Release Q1 2024 ALX Oncology Holdings Inc Earnings ReleaseForecast(預報) -返回 - |
Friday, June 14, 2024 | ||
時間 (UTC) 20:00 | 國家 US
| 事件 ALX Oncology Holdings Inc Annual Shareholders Meeting ALX Oncology Holdings Inc Annual Shareholders MeetingForecast(預報) -返回 - |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 1.182 | 4.796 | 2.067 |
收入 | 0 | 0 | 1.182 | 4.796 | 2.067 |
收入成本,共計 | 0 | 1.075 | 4.36 | 1.88 | |
毛利 | 0 | 0.107 | 0.436 | 0.187 | |
總營業費用 | 127.436 | 83.555 | 45.466 | 23.979 | 15.751 |
銷售/一般/行政費用,總計 | 29.036 | 23.385 | 14.809 | 3.313 | 2.601 |
研究與開發 | 98.4 | 60.17 | 28.961 | 16.306 | 11.27 |
營業收入 | -127.436 | -83.555 | -44.284 | -19.183 | -13.684 |
利息收入(費用),非經營淨值 | 4.278 | -0.013 | -0.811 | -0.021 | 0 |
其他,淨值 | -0.26 | 0.084 | -0.404 | -0.005 | -0.002 |
稅前淨收入 | -123.418 | -83.484 | -45.499 | -19.209 | -13.686 |
稅後淨收入 | -123.482 | -83.463 | -45.74 | -19.243 | -13.731 |
未計算非常項目前的淨收益 | -123.482 | -83.463 | -45.74 | -19.243 | -13.731 |
淨收入 | -123.482 | -83.463 | -45.74 | -19.243 | -13.731 |
Total Adjustments to Net Income | 0 | 0 | -5.202 | -4.028 | -3.671 |
普通股股東可獲收益 (不含非經常性項目) | -123.482 | -83.463 | -50.942 | -23.271 | -17.402 |
普通股股東可獲收益 (含非經常性項目) | -123.482 | -83.463 | -50.942 | -23.271 | -17.402 |
攤薄淨收入 | -123.482 | -83.463 | -50.942 | -23.271 | -17.402 |
攤薄後加權平均股 | 40.6996 | 40.308 | 18.4853 | 34.7116 | 34.7116 |
扣除特別項目的每股攤薄盈利 | -3.03398 | -2.07063 | -2.7558 | -0.67041 | -0.50133 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | |||
每股正常攤薄盈利 | -3.03398 | -2.07063 | -2.73397 | -0.67041 | -0.50133 |
異常費用(收入) | 0 | 0 | 0.621 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
總收入 | 0 | 0 | 0 | 0 | 0 |
收入 | |||||
總營業費用 | 36.777 | 32.203 | 32.219 | 36.681 | 33.789 |
銷售/一般/行政費用,總計 | 7.295 | 7.44 | 7.022 | 7.299 | 7.041 |
研究與開發 | 29.482 | 24.763 | 25.197 | 29.382 | 26.748 |
營業收入 | -36.777 | -32.203 | -32.219 | -36.681 | -33.789 |
利息收入(費用),非經營淨值 | 2.294 | 1.924 | 1.807 | 1.37 | 0.876 |
其他,淨值 | 0.324 | 0.095 | -0.233 | -0.009 | -0.007 |
稅前淨收入 | -34.159 | -30.184 | -30.645 | -35.32 | -32.92 |
稅後淨收入 | -34.159 | -30.184 | -30.709 | -35.32 | -32.92 |
未計算非常項目前的淨收益 | -34.159 | -30.184 | -30.709 | -35.32 | -32.92 |
淨收入 | -34.159 | -30.184 | -30.709 | -35.32 | -32.92 |
Total Adjustments to Net Income | |||||
普通股股東可獲收益 (不含非經常性項目) | -34.159 | -30.184 | -30.709 | -35.32 | -32.92 |
普通股股東可獲收益 (含非經常性項目) | -34.159 | -30.184 | -30.709 | -35.32 | -32.92 |
攤薄淨收入 | -34.159 | -30.184 | -30.709 | -35.32 | -32.92 |
攤薄後加權平均股 | 40.8755 | 40.8625 | 40.7459 | 40.747 | 40.6878 |
扣除特別項目的每股攤薄盈利 | -0.83568 | -0.73867 | -0.75367 | -0.86681 | -0.80909 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常攤薄盈利 | -0.83568 | -0.73867 | -0.75367 | -0.86681 | -0.80909 |
收入成本,共計 | |||||
毛利 | |||||
異常費用(收入) | 0 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
流動資産總額 | 270.969 | 367.019 | 435.992 | 9.809 | 10.208 |
現金和短期投資 | 266.207 | 363.667 | 434.219 | 9.017 | 8.262 |
現金 | 434.219 | 9.017 | 8.262 | ||
應收賬款總額,淨額 | 0 | 0.536 | 0.932 | ||
應收賬款 - 貿易,淨額 | 0 | 0.536 | 0.932 | ||
預付的費用 | 4.762 | 3.352 | 1.773 | 0.256 | 1.014 |
總資産 | 306.489 | 380.183 | 436.054 | 10.676 | 11.164 |
物業/廠房/設備,總計 - 淨額 | 9.789 | 3.397 | 0.052 | 0.86 | 0.956 |
物業/廠房/設備,總計 - 總額 | 10.192 | 3.46 | 0.077 | 2.309 | 1.976 |
累計折舊,總計 | -0.403 | -0.063 | -0.025 | -1.449 | -1.02 |
其他長期資産,總計 | 9.032 | 9.767 | 0.01 | 0.007 | 0 |
流動負債總額 | 28.325 | 15.295 | 6.204 | 4.984 | 1.873 |
應付賬款 | 8.073 | 3.764 | 0.004 | 3.748 | 0.697 |
預提費用 | 19.792 | 11.102 | 6.049 | 1.046 | 0.905 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
其他流動負債,總計 | 0.174 | 0.151 | 0.19 | 0.271 | |
負債總額 | 43.025 | 17.134 | 6.209 | 10.952 | 2.009 |
長期債務總額 | 9.389 | 0.28 | 0 | 5.421 | 0 |
長期債務 | 9.389 | 5.421 | 0 | ||
其他負債,總計 | 5.311 | 1.559 | 0.005 | 0.547 | 0.136 |
股權 | 263.464 | 363.049 | 429.845 | -0.276 | 9.155 |
Preferred Stock - Non Redeemable, Net | 70.363 | 60.933 | |||
普通股 | 0.041 | 0.041 | 0.04 | 0.021 | 0.021 |
額外實收資本 | 589.735 | 564.993 | 548.327 | 2.122 | 1.74 |
留存收益(累計赤字) | -325.467 | -201.985 | -118.522 | -72.782 | -53.539 |
總負債和股東權益 | 306.489 | 380.183 | 436.054 | 10.676 | 11.164 |
已發行普通股總數 | 40.8614 | 40.5871 | 39.8445 | 34.7116 | 34.7116 |
Redeemable Preferred Stock | 0 | ||||
現金等價物 | 48.822 | 363.667 | |||
長期債務的當前部分/資本租賃 | 0.286 | 0.429 | |||
資本租賃義務 | 0 | 0.28 | |||
短期投資 | 217.385 | ||||
長期投資 | 16.699 | ||||
其他權益,總計 | -0.845 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
流動資産總額 | 199.071 | 219.561 | 232.536 | 270.969 | 290.808 |
現金和短期投資 | 190.009 | 212.836 | 227.944 | 266.207 | 284.909 |
現金等價物 | 19.584 | 38.039 | 63.194 | 48.822 | 49.054 |
預付的費用 | 8.462 | 6.225 | 3.792 | 4.762 | 5.899 |
總資産 | 220.107 | 245.932 | 278.138 | 306.489 | 317.689 |
物業/廠房/設備,總計 - 淨額 | 9.808 | 9.066 | 9.551 | 9.789 | 8.639 |
物業/廠房/設備,總計 - 總額 | 10.84 | 9.889 | 10.167 | 10.192 | 8.939 |
累計折舊,總計 | -1.032 | -0.823 | -0.616 | -0.403 | -0.3 |
其他長期資産,總計 | 4.793 | 5.658 | 7.831 | 9.032 | 10.025 |
流動負債總額 | 35.142 | 17.572 | 21.891 | 28.325 | 25.243 |
應付賬款 | 13.001 | 4.115 | 9.826 | 8.073 | 5.88 |
預提費用 | 21.151 | 12.409 | 11.628 | 19.792 | 18.97 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 0.179 | 0.286 | 0.393 | ||
其他流動負債,總計 | 0.99 | 1.048 | 0.258 | 0.174 | |
負債總額 | 51.355 | 33.24 | 37.75 | 43.025 | 30.726 |
長期債務總額 | 9.575 | 9.512 | 9.45 | 9.389 | 0 |
資本租賃義務 | 0 | 0 | 0 | ||
其他負債,總計 | 6.638 | 6.156 | 6.409 | 5.311 | 5.483 |
股權 | 168.752 | 212.692 | 240.388 | 263.464 | 286.963 |
Redeemable Preferred Stock | |||||
普通股 | 0.041 | 0.041 | 0.041 | 0.041 | 0.041 |
額外實收資本 | 609.737 | 602.773 | 596.086 | 589.735 | 583.184 |
留存收益(累計赤字) | -440.8 | -389.81 | -355.651 | -325.467 | -294.758 |
總負債和股東權益 | 220.107 | 245.932 | 278.138 | 306.489 | 317.689 |
已發行普通股總數 | 41.1518 | 40.9922 | 40.863 | 40.8614 | 40.7483 |
短期投資 | 170.425 | 174.797 | 164.75 | 217.385 | 235.855 |
長期投資 | 6.435 | 11.647 | 28.22 | 16.699 | 8.217 |
其他權益,總計 | -0.226 | -0.312 | -0.088 | -0.845 | -1.504 |
長期債務 | 9.575 | 9.512 | 9.45 | 9.389 | |
應收賬款總額,淨額 | 0.6 | 0.5 | 0.8 |
- 每年
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
淨收入/起跑線 | -123.482 | -83.463 | -45.74 | -19.243 | -13.731 |
經營活動産生的現金 | -89.223 | -68.101 | -38.289 | -14.249 | -13.19 |
經營活動産生的現金 | 0.342 | 0.051 | 0.202 | 0.429 | 0.431 |
非現金物品 | 24.067 | 19.338 | 7.002 | 0.308 | 0.269 |
營運資金的變化 | 9.85 | -4.027 | 0.247 | 4.257 | -0.159 |
投資活動産生的現金 | -235.416 | -4.923 | 0.61 | -0.353 | -0.653 |
資本支出 | -1.427 | -4.923 | -0.031 | -0.353 | -0.653 |
融資活動産生的現金 | 9.86 | 2.472 | 462.881 | 15.357 | 0.001 |
股票的發行(報廢),淨額 | 0.903 | 2.753 | 473.235 | 9.44 | 0.001 |
債務的發行(退還),淨額 | 9.612 | -0.281 | 0 | 5.917 | 0 |
現金淨變化 | -314.779 | -70.552 | 425.202 | 0.755 | -13.842 |
Cash Taxes Paid | 0 | 0.274 | 0.047 | ||
已付現金利息 | 0.103 | 0.011 | 0.427 | ||
其他投資現金流量項目,總計 | -233.989 | 0.641 | |||
融資現金流項目 | -0.655 | -10.354 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -30.184 | -123.482 | -92.773 | -57.453 | -24.533 |
Cash From Operating Activities | -27.816 | -89.223 | -68.555 | -37.672 | -20.674 |
Cash From Operating Activities | 0.213 | 0.342 | 0.237 | 0.142 | 0.058 |
Non-Cash Items | 5.603 | 24.067 | 18.104 | 11.954 | 5.926 |
Cash Interest Paid | 0 | 0.103 | 0 | 0 | 0 |
Changes in Working Capital | -3.448 | 9.85 | 5.877 | 7.685 | -2.125 |
Cash From Investing Activities | 42.295 | -235.416 | -246.358 | -260.053 | -183.921 |
Capital Expenditures | -0.69 | -1.427 | -1.038 | -0.846 | -0.589 |
Cash From Financing Activities | -0.107 | 9.86 | 0.366 | 0.502 | 0.08 |
Issuance (Retirement) of Stock, Net | 0 | 0.903 | 0.647 | 0.642 | 0.185 |
Net Change in Cash | 14.372 | -314.779 | -314.547 | -297.223 | -204.515 |
Cash Taxes Paid | 0 | 0 | 0 | 0 | 0 |
Financing Cash Flow Items | -0.655 | ||||
Issuance (Retirement) of Debt, Net | -0.107 | 9.612 | -0.281 | -0.14 | -0.105 |
Other Investing Cash Flow Items, Total | 42.985 | -233.989 | -245.32 | -259.207 | -183.332 |
差價合約交易計算器
計算您的假設損益
交易佣金
0
- 1:1
槓桿
1:1
- 20
- 100
- 500
- 1000
- 10000
交易
交易規模(槓桿 x 投資):
打開
拋售
已賣出 做多
Industry: | Bio Therapeutic Drugs |
323 Allerton Avenue
SOUTH SAN FRANCISCO
CALIFORNIA 94080
US
盈虧控制
- Annual
- Quarterly
人們也觀看
還在尋找值得信賴的經紀商?
加入全球 610,000 多名交易者,選擇與 Capital.com 交易